ATARA BIOTHERAPEUTICS, INC. Asset Retirement Obligation, Liabilities Incurred
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Asset Retirement Obligation, Liabilities Incurred of $88.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes
us-gaap:AssetRetirementObligationLiabilitiesIncurred · last filed 2019-02-26
- ATARA BIOTHERAPEUTICS, INC. asset retirement obligation, liabilities incurred for the quarter ending 2018-12-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. asset retirement obligation, liabilities incurred for the quarter ending 2018-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. asset retirement obligation, liabilities incurred for the quarter ending 2018-06-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. asset retirement obligation, liabilities incurred for the quarter ending 2018-03-31 was $88.00K.
- ATARA BIOTHERAPEUTICS, INC. asset retirement obligation, liabilities incurred for fiscal 2018 was $88.00K, a 84.83% decline from fiscal 2017.
- ATARA BIOTHERAPEUTICS, INC. asset retirement obligation, liabilities incurred for fiscal 2017 was $580.00K.
| Period end | Asset Retirement Obligation, Liabilities Incurred 3 month | Asset Retirement Obligation, Liabilities Incurred 6 month | Asset Retirement Obligation, Liabilities Incurred 9 month | Asset Retirement Obligation, Liabilities Incurred 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $88.00K 10-K · filed 2019-02-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $88.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $88.00K 10-Q · filed 2018-08-01 | ||
| 2018-03-31 | $88.00K 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $580.00K 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |